Xiao Feng Chen
Directeur/Membre du Conseil chez Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd.
Postes actifs de Xiao Feng Chen
Sociétés | Poste | Début | Fin |
---|---|---|---|
Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | Directeur/Membre du Conseil | 19/08/2011 | - |
Historique de carrière de Xiao Feng Chen
Anciens postes connus de Xiao Feng Chen
Sociétés | Poste | Début | Fin |
---|---|---|---|
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of Sino Biopharmaceutical Ltd., Chia Tai Tianqing Pharmaceutical Group Co., Ltd. is an innovative pharmaceutical group enterprise based in Lianyungang, China. Chia Tai Tianqing has six major product groups, including liver disease, anti-tumor, respiratory, infection, endocrine, and cardiovascular and cerebrovascular. The Chinese company invests heavily in innovative drug research and has high-level R & D platforms such as the national enterprise technology center. Chia Tai Tianqing is preparing for a number of products to enter the international market and actively undertakes corporate social responsibilities. The company was founded in 1969, and the CEO is Kang Xin Yu. | Directeur/Membre du Conseil | 19/08/2011 | - |
SINO BIOPHARMACEUTICAL LIMITED | Comptroller/Controller/Auditor | 19/08/2011 | - |
Statistiques
Internationale
Chine | 3 |
Hong Kong | 2 |
Opérationnelle
Director/Board Member | 2 |
Comptroller/Controller/Auditor | 1 |
Sectorielle
Health Technology | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 1 |
---|---|
SINO BIOPHARMACEUTICAL LIMITED | Health Technology |
Entreprise privées | 2 |
---|---|
Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | |
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of Sino Biopharmaceutical Ltd., Chia Tai Tianqing Pharmaceutical Group Co., Ltd. is an innovative pharmaceutical group enterprise based in Lianyungang, China. Chia Tai Tianqing has six major product groups, including liver disease, anti-tumor, respiratory, infection, endocrine, and cardiovascular and cerebrovascular. The Chinese company invests heavily in innovative drug research and has high-level R & D platforms such as the national enterprise technology center. Chia Tai Tianqing is preparing for a number of products to enter the international market and actively undertakes corporate social responsibilities. The company was founded in 1969, and the CEO is Kang Xin Yu. | Health Technology |
- Bourse
- Insiders
- Xiao Feng Chen
- Expérience